Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Alphavalue ajuste sa valorisation sur le titre Biomerieux ce lundi 2 mars 2026.
In vitro diagnostics group bioMérieux recorded a revenue of 4,070 million euros in 2025, marking an organic growth of 6.2%. The contributory operating…
French company bioMérieux announced on February 18, 2026, the launch of SMARTBIOME, a solution aimed at the agri-food industry to better understand an…
Oddo BHF établit une recommandation surperformer sur Biomerieux et fixe un objectif de cours à 110 €.
The stock of bioMérieux, a French specialist in in vitro diagnostics, has had a tough week. The share price closed on Friday at 97.80 euros, marking a…
On Wednesday, January 28, bioMérieux shares recorded a significant decline of 2.79%, reaching 99.15 euros from 102 euros the previous day. This downtu…
The in vitro diagnostics group bioMérieux announced on Thursday the acquisition of the American company Accellix, which specializes in automated flow …
Biomerieux experienced a challenging week, with a decline of 8%, which starkly contrasts with the relative stability of major indices. The stock close…
bioMérieux shares closed on Wednesday, January 7th at 113.50 euros, marking a decline of 1.13% from the previous day, facing technical resistance at 1…
Biomérieux has announced the launch of a new product dedicated to the equine sector, according to a press release dated December 4, 2025.
